| dbo:abstract
|
- TopoTarget (Nasdaq Copenhagen: TOPO) was a Copenhagen-based biotechnology company focused on the discovery and development of drugs and therapies to treat cancer. In 2014, it merged with BioAlliance Pharma and is now part of . It was founded in 2000 by a group of clinicians. TopoTarget was involved in collaborations with both academia and industry. In 2001 they began collaborating with the National Cancer Institute, a component of the US National Institutes of Health. Since their acquisition of , they have been collaborating with the Netherlands Cancer Institute. They also collaborate with Rigshospitalet, the national hospital of Denmark. TopoTarget has also collaborated with other companies, including Novartis since 2003, and Lundbeck as of October 2007; Topotarget has been member of the Danish Innovation Network Biopeople since 2005. (en)
|
| dbo:assets
| |
| dbo:equity
| |
| dbo:foundingYear
| |
| dbo:industry
| |
| dbo:keyPerson
| |
| dbo:location
| |
| dbo:netIncome
| |
| dbo:numberOfEmployees
|
- 53 (xsd:nonNegativeInteger)
- 68 (xsd:nonNegativeInteger)
|
| dbo:operatingIncome
| |
| dbo:revenue
| |
| dbo:thumbnail
| |
| dbo:type
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 29390 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:assets
|
- DKK 585.41 million , p. 24 (en)
|
| dbp:equity
|
- DKK 411.79 million , p. 24 (en)
|
| dbp:foundation
| |
| dbp:homepage
| |
| dbp:industry
| |
| dbp:keyPeople
|
- (en)
- Anders Fink Vadsholt (en)
- Bo Jesper Hansen (en)
- Francois Martelet (en)
- Jean-Louis Misset (en)
- Peter Buhl Jensen (en)
|
| dbp:location
| |
| dbp:logo
| |
| dbp:name
| |
| dbp:netIncome
|
- DKK 140.46 million , p. 24 (en)
|
| dbp:numEmployees
| |
| dbp:operatingIncome
|
- DKK 132.49 million , p. 24 (en)
|
| dbp:revenue
|
- DKK 43.979 million , p. 24 (en)
|
| dbp:type
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- TopoTarget (Nasdaq Copenhagen: TOPO) was a Copenhagen-based biotechnology company focused on the discovery and development of drugs and therapies to treat cancer. In 2014, it merged with BioAlliance Pharma and is now part of . (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
